A PYMNTS Company

China: Johnson & Johnson monopoly ruling hits several milestones for antitrust law

By  |  August 1, 2013

Johnson & Johnson became the first Fortune 500 company to be ruled a monopoly by a Chinese court, say reports. The decision reflects the nation’s strengthening position against price-fixing, say analysts. The verdict, delivered Thursday, ordered the US-based pharmaceutical giant to pay about $86,500 to an ex-dealer on which J&J imposed a price floor, said the Shanghai High People’s Court. The company forced minimum retail prices on its former China-based dealer Rainbow Medical. Chief judge Ding Wenlian said the medical instrument market in the nation has “faced a lack of competition. The ruling marks the first antitrust ruling in favor of the plaintiff, and the first vertical monopoly lawsuit in China since the establishment of the nation’s Anti-monopoly Law, which went into effect five years ago.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Full Content: China Daily

    We’d love to be your preferred source for news.

    Please add us to your preferred sources list so our news, data and interviews show up in your feed. Thanks!

    Add as Preferred Source

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.